Form 4: FMR LLC Reduces Beam Therapeutics Stake

FMR LLC, a 10% owner of Beam Therapeutics Inc., reported a disposition of 1,232,434 common shares via a gift or distribution.

Summary

• FMR LLC, identified as a 10% owner of Beam Therapeutics Inc. (BEAM), reported a disposition of 1,232,434 shares of common stock.
• The transaction occurred on October 6, 2025, and was categorized with Transaction Code 'G', indicating a gift, in-kind contribution, or distribution, with a reported price of $0.00 per share.
• Following this transaction, FMR LLC's beneficial ownership totals 1,981,147 shares, held indirectly through various entities.
• Indirect ownership includes 1,139,443 shares via F-Prime Capital Partners Healthcare Fund V LP, 473 shares via FMR Capital, Inc., and 841,231 shares held by other persons and entities subject to FMR LLC's reporting.

Sentiment

Score: 4

Explanation: The disposition of a significant number of shares by a 10% owner, even if a gift/distribution, is generally viewed as a moderately negative signal, indicating a reduction in exposure or conviction.

Negatives

• A significant reduction in beneficial ownership by a 10% owner, even if a gift or distribution, can be interpreted as a decrease in conviction or a strategic portfolio rebalancing away from the issuer.
• The disposition of 1,232,434 shares represents a notable reduction in FMR LLC's exposure to Beam Therapeutics Inc.

Risks

• Potential negative market perception due to a large shareholder reducing their stake, which could impact investor confidence.
• The reduction in ownership by a significant institutional investor might signal a re-evaluation of the investment's long-term prospects.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• F-Prime Capital Partners Healthcare Fund V LP and FMR Capital, Inc. are entities through which FMR LLC indirectly holds shares. F-Prime Capital Partners Healthcare Fund V LP's general partner is solely managed by Impresa Management LLC, which is owned by shareholders and employees of FMR LLC, including certain members of the Johnson family. FMR Capital, Inc. is a wholly owned subsidiary of FMR LLC.

Stakeholder Impact

• Shareholders: May interpret the disposition as a negative signal, potentially leading to decreased investor confidence and downward pressure on the stock price.
• Investment Professionals: Will note the reduction in exposure by a major institutional investor, potentially influencing their own investment recommendations.

Key Dates

Recommendation

While the disposition of over 1.2 million shares by a 10% owner is a significant event, the transaction code 'G' indicates it was a gift or distribution rather than a direct market sale for profit. This mitigates some of the negative sentiment associated with a typical insider sale. However, it still represents a reduction in exposure by a major institutional investor. Investors should 'hold' and monitor future filings and company performance for further clarity on FMR LLC's long-term strategy regarding Beam Therapeutics Inc.

Keywords

FMR LLC, Beam Therapeutics, BEAM, Form 4, Insider Transaction, Beneficial Ownership, Stock Disposition, Gift, Distribution, Institutional Investor